Thrombotic risk of platinum combination chemotherapy with and without immune checkpoint inhibitors for advanced non-small cell lung cancer: a nationwide inpatient database study

OBJECTIVES: To determine the associated thromboembolism risk with adding immune checkpoint inhibitors (ICI) to platinum combination chemotherapy compared with platinum combination chemotherapy alone in patients with advanced non-small cell lung cancer. MATERIALS AND METHODS: This study identified 75...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwai, Chikako, Jo, Taisuke, Konishi, Takaaki, Fujita, Asahi, Michihata, Nobuaki, Matsui, Hiroki, Fushimi, Kiyohide, Yasunaga, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576683/
https://www.ncbi.nlm.nih.gov/pubmed/37540262
http://dx.doi.org/10.1007/s00262-023-03508-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576683/
https://www.ncbi.nlm.nih.gov/pubmed/37540262
http://dx.doi.org/10.1007/s00262-023-03508-1

Ejemplares similares